S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%S&P 500 5,235.18 +1.02%EUR/USD 1.0840 +0.21%GBP/USD 1.2710 +0.14%USD/JPY 149.50 −0.18%BRENT $82.40 −0.81%BTC $67,800 −0.21%GOLD $2,341 +0.55%NASDAQ 16,420.55 +0.74%
A daily business newspaper · Founded in 2026

Money Talk

Finance and markets: business, quotes, gold, energy and releases.

Alignment Healthcare Faces Securities Probe After Whistleblower Claims

A 16.7% single-day stock plunge has triggered a formal investigation by Hagens Berman into Alignment Healthcare, following allegations that the firm manipulated its financial records. A former executive claims the company artificially inflated its 2024 and 2025 earnings by misclassifying operating expenses as capital expenditures.

Alignment Healthcare Faces Securities Probe After Whistleblower Claims
Photo: Bio & News

The investigation centers on a lawsuit filed by Hakan Kardes, who served as Alignment’s chief transformation officer from 2019 to 2025. Kardes alleges that the company engaged in deliberate accounting irregularities to bolster its adjusted EBITDA, a move that purportedly influenced both executive compensation packages and the company's market valuation. These accusations surface just as Alignment had reported a strong first quarter in 2026, which initially pushed share prices toward 52-week highs.

Reed Kathrein, the partner at Hagens Berman spearheading the inquiry, stated the firm is examining whether Alignment misled investors through false disclosures regarding its internal financial controls. The investigation specifically targets the potential for securities law violations that left shareholders with substantial losses. Current efforts are focused on gathering evidence from investors and individuals with non-public information, with the firm noting the availability of SEC whistleblower incentives for those providing original data.

Share article
TelegramXFacebook

When reusing this material a link to Money Talk is required.

Comments (0)

Leave a comment

No comments yet. Be the first!